NCT02821715View on ClinicalTrials.gov

Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

February 28, 2019

Conditions
Narcolepsy
Interventions
DRUG

Active comparator: Modafinil + placebo

DRUG

THN102 300/3

DRUG

THN102 300/27

Trial Locations (8)

33076

CHU Pellegrin, Bordeaux

34090

University Hospital, Montpellier

59037

CHRU Lilles, Lille

75013

Groupe Hospitalier Pitié Salpêtrière, Paris

92380

Hôpital Raymond Poincaré, Garches

Unknown

RespiSom, Erpent

CHU Dijon Bourgogne, Dijon

CHU Grenoble Alpes, Grenoble

Sponsors

Lead Sponsor

Theranexus
All Listed Sponsors
lead

Theranexus

INDUSTRY

NCT02821715 - Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients | Biotech Hunter | Biotech Hunter